Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: The University of California-San Francisco experience

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 4, 2007, Pages 1106-1112

  Lee, Brian ^a   Shinohara, Katsuto ^b   Weinberg, Vivian ^c   Gottschalk, Alexander R ^a   Pouliot, Jean ^a   Roach III, Mack ^a   Hsu, I Chow ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

High dose rate brachytherapy; Prostate; Radiation failure; Recurrence; Salvage

Indexed keywords

BIOCHEMICAL ENGINEERING; DISEASES; IMPLANTS (SURGICAL); PATIENT TREATMENT; TOXICITY; TUMORS;

EXTERNAL BEAM RADIOTHERAPY (EBRT); HIGH-DOSE RATE BRACHYTHERAPY; PROSTATE; RADIATION FAILURE;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BIOCHEMICAL FAILURE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SAFETY; SALVAGE THERAPY; SEXUAL DYSFUNCTION; TREATMENT FAILURE; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DOSE FRACTIONATION; FEASIBILITY STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33847279426     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.10.012     Document Type: Article

References (36)

1. Beyer D.C. Brachytherapy for recurrent prostate cancer after radiation therapy. Semin Radiat Oncol 13 (2003) 158-165
2. Syed A.M., Puthawala A., Sharma A., et al. High-dose-rate brachytherapy in the treatment of carcinoma of the prostate. Cancer Control 8 (2001) 511-521
3. Hsu I.C., Cabrera A.R., Weinberg V., et al. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy 4 (2005) 202-206
4. Nag S., Martinez-Monge R., Copeland L.J., et al. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina. Gynecol Oncol 66 (1997) 16-19
5. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
6. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52 (2002) 6-13
7. King C.R., and Fowler J.F. A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. Int J Radiat Oncol Biol Phys 51 (2001) 213-214
8. Fowler J., Chappell R., and Ritter M. Is alpha/beta for prostate tumors really low?. Int J Radiat Oncol Biol Phys 50 (2001) 1021-1031
9. D'Souza W.D., and Thames H.D. Is the alpha/beta ratio for prostate cancer low?. Int J Radiat Oncol Biol Phys 51 (2001) 1-3
10. Lessard E., and Pouliot J. Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. Med Phys 28 (2001) 773-779
11. Hsu I.C., Lessard E., Weinberg V., et al. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. Brachytherapy 3 (2004) 147-152
12. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
13. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
14. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
15. Kuban D.A., el-Mahdi A.M., and Schellhammer P.F. Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma. Cancer 63 (1989) 2421-2425
16. Lee W.R., Hanks G.E., and Hanlon A. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations. J Clin Oncol 15 (1997) 230-238
17. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
18. Sylvester J., Grimm P., Blasco J., et al. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: A survey of practice patterns of urologists and radiation oncologists in the United States. Urology 58 (2001) 65-70
19. Chen B.T., and Wood Jr. D.P. Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer. Urology 62 Suppl 1 (2003) 69-78
20. Amling C.L., Lerner S.E., Martin S.K., et al. Deoxyribonucleic acid ploidy and serum prostate-specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 161 (1999) 857-862
21. Bianco Jr. F.J., Scardino P.T., Stephenson A.J., et al. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 448-453
22. Shekarriz B., Upadhyay J., and Pontes J.E. Salvage radical prostatectomy. Urol Clin North Am 28 (2001) 545-553
23. Izawa J.I., Madsen L.T., Scott S.M., et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: Variables affecting patient outcome. J Clin Oncol 20 (2002) 2664-2671
24. Chin J.L., Pautler S.E., Mouraviev V., et al. Results of salvage cryoablation of the prostate after radiation: Identifying predictors of treatment failure and complications. J Urol 165 (2001) 1937-1941 discussion 1941-1932
25. Bahn D.K., Lee F., Silverman P., et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: A seven-year follow-up. Clin Prostate Cancer 2 (2003) 111-114
26. Anastasiadis A.G., Sachdev R., Salomon L., et al. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol 129 (2003) 676-682
27. Trachtenberg J., Chen J., Kucharczyk W., et al. Microwave thermoablation for localized prostate cancer after failed radiation therapy: Role of neoadjuvant hormonal therapy. Mol Urol 3 (1999) 247-250
28. Master V.A., Shinohara K., and Carroll P.R. Ferromagnetic thermal ablation of locally recurrent prostate cancer: Prostate-specific antigen results and immediate/intermediate morbidities. J Urol 172 (2004) 2197-2202
29. Gelet A., Chapelon J.Y., Poissonnier L., et al. Local recurrence of prostate cancer after external beam radiotherapy: Early experience of salvage therapy using high-intensity focused ultrasonography. Urology 63 (2004) 625-629
30. Grado G.L., Collins J.M., Kriegshauser J.S., et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53 (1999) 2-10
31. Theodorescu D., Gillenwater J.Y., and Koutrouvelis P.G. Prostatourethral-rectal fistula after prostate brachytherapy. Cancer 89 (2000) 2085-2091
32. Beyer D.C. Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54 (1999) 880-883
33. Galalae R.M., Kovacs G., Schultze J., et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 81-90
34. Martinez A., Gonzalez J., Spencer W., et al. Conformal high-dose-rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol 169 (2003) 974-980
35. Gamie SH SN, Puthawala A, Mustafa E, et al. Re-irradiation for locally recurrent prostate cancer using termporary interstitial Ir-192 implant technique. American Brachytherapy Society 23rd Annual Meeting (Abstracts) 2002:56.
36. Wang-Chesebro A.P.J., Lessard E., Roach III M., and Hsu I.-C. Can inverse planning further reduce dose to urethra for prostate high-dose-rate (HDR) brachytherapy boost?. Int J Radiat Oncol Biol Phys 66 (2006) S367 [Abstract].(Suppl.)